维普中文期刊产品整合服务
124篇 您的检索式:作者名="Shishehbor"
    题名 作者 年代 出处 被引量
1A new kinetic spectrophotometric method for the determination of major metabolite of heroin in biological samples显示文摘这研究在生物样品为 6-monoacetylmorphine (6-MAM ) 的决心把一个简单、快速、选择的催化运动 spectrophotometric 方法描述为海洛因的主要代谢物。方法被使与臬化合在酸媒介在 6-MAM 的催化效果之上基于贾努斯·格林的氧化。反应被在 618 nm 在贾努斯·格林的吸收度测量减少 spectrophotometrically 跟随。反应变量上的敏感的依赖被学习。在最佳条件下面,二线性刻度在范围上弯 0.11.0 g mL1 和 6-MAM 的 1.034.0 g mL1 被获得。察觉限制是 1.2 e 能显著地增加M.Reza Shishehbore Ali Sheibani Ehsan Mirparizi 2012Chinese Chemical Letters2012,23,5:2
2Kinetic spectrophotometric determination of bromide in clidinium-c drug显示文摘一个简单、快速、敏感的方法为溴化物的踪迹数量的决心被描述了。方法在硫磺的酸媒介由使与臬化合在甲又蓝色的氧化上基于溴化物离子的催化效果。反应被在 665 nm 在甲又蓝色的吸收度测量减少 spectrophotometrically 监视。溴化物与 0.03 g/mL 的察觉限制在 0.051.90 g/mL 的范围被决定。五的相对标准差复制溴化物的 0.20 和 10.0 g/mL 的决心分别地是 2.4% 和 1.8% 。潜在的介入离子和物质的影响被学习。方法作为一件真实样品在 clidinium-c 药片被用于溴化物的分析。Ali Sheibani M.Reza Shishehbore Zahra Tavakolian Ardakani 2011Chinese Chemical Letters2011,22,5:2
3Highly selective catalytic speetrophotometrie method for the determination of nitrite 显示文摘Mazloum A M Shishehbore M R Nasirzadeh N 2006Canadian J Anal Sciences and Spectroscopy2006,51,11:1
4Using C - reactive Protein to assess cardiovascular disease risk显示文摘Shishehbor MH Bhatt DL Topoi EJ 2003Cleve Clin J Med2003,70,:1
5A Direct Comparison of Early and Late Outcomes With Three Approaches to Carotid Revascularization and Open Heart Surgery显示文摘Shishehbor MH Venkatachalam S Sun Z 2013J Am Coil Cardio12013,62,21:1
6Statins promote potent systemic antioxid effects through specific inflammatory pathways显示文摘SHISHEHBOR M H BRENNAN M L AVILES R J 2003Circulation2003,108,4:1
7Basic Data Related to Endovascular Management of Peripheral Arterial Disease in Critical Limb Ischemia显示文摘Sridhar Venkatachalam Mehdi H. Shishehbor Bruce H. Gray 2012Annals of Vascular Surgery2012,,:1
8The association between early ventricular arrhythmias,renin-angiotensin-aldosterone system antagonism,and mortality in patients with ST-segment-elevation myocardial infarction;Insights from global use of strategies to open coronary arteries (GUSTO) V显示文摘Askari A T Shishehbor M H Kaminski M A 0,,02:1
9A review of high- dose statin therapy: targeting cholesterol and iifflammation in atherosclerosis 显示文摘Patel TN Shishehbor MH Bhatt DL 2007Eur Heart J2007,28,6:1
10High-density lipoprotein as a therapeutic target:a systematic review 显示文摘Singh IM Shishehbor MH Ansell BJ 2007JAMA2007,298,7:1
11Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy显示文摘 Aviles R J Brennan ML 2003JAMA2003,289,13:1
12Association of nitro- tyrosine levels with cardiovascular disease and modulation by statin therapy显示文摘Shishehbor MH Aviles RJ Brennan ML 2003JAMA2003,289,13:1
13High-density lipoprotein as a therapeutic target:a systematic review显示文摘Singh IM Shishehbor MH Ansell BJ 2007J Am Med Assoc2007,298,7:1
14Inflammatory and oxidative markers in atherosclerosis:relationship to outcome显示文摘Shishehbor M H Hazen S L 2004Curr Atheroscler Rep2004,6,3:1
15High-density lipoprotein as a therapeutic target:a systematic review显示文摘Singh IM Shishehbor MH Amsell B J 2007JAMA2007,298,7:1
16New hypertension guidelines: one size fits most? 显示文摘Thomas G Shishehbor M Brill D 2014CleveClinJ Med2014,81,3:1
17High-density lipoprotein as a therapeutic target: a systematic review 显示文摘Singh IMp Shishehbor MH Ansell BJ 2007JAMA2007,298,7:1
18Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy 显示文摘Shishehbor MH Aviles RJ Brennan ML 2003JAMA2003,289,13:1
19High-density lipoprotein as a therapeutic target:a systematic review显示文摘Singh IM Shishehbor MH Ansell BJ 2007JAMA2007,298,7:1
20Statins promote potent systemic antioxidant effects through specific inflammatory pathways显示文摘Shishehbor MH Brennan ML Aviles RJ 2003Circulation2003,108,4:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费